Vall Hebron University Hospital
Barcelona, Spain
Elena Élez obtained her medical degree at the “Universitat de Lleida” (UdL) in 2002. Her specialization as medical oncology was at “Institut Català d'Oncología” (ICO) in Bellvitge's University Hospital and completed her formation with a Master in Molecular Oncology in the National Center of Investigations Oncologic (CNIO). In 2015 obtained “Cum Laude” qualification when she completes her studies of doctorate with the doctoral thesis: "Colorectal Cancer refractory metastatic, paper of the medicaments that intervene in MET's route and integrinas ".
Elena Elez MD is attending Physician Medical Oncology Service –Gastrointestinal Oncology Unit since 2007 at Vall Hebron University Hospital and takes part as principal investigator and sub-investigator of clinical trials focused in development of new drug particularly in colorectal metastatic cancer. In concrete, molecular populations selected especially in adenocarcinoma from colon mutated BRAF as well as identification of factors of primary or secondary resistance to treatments anti-EGFR. Dra Elez is member of cooperative groups like TTD, and ASCO, ESMO, SEOM and AACR.
She has taken part and contributed in the design of clinical tests that include trials initiated by the investigator, trials developed in the context of cooperative national and international groups, and trials that are supported by pharmaceutical companies.
Thursday, June 30, 2022
13:10 – 13:30
Thursday, June 30, 2022
14:20 – 14:35
Friday, July 1, 2022
13:40 – 15:10
Friday, July 1, 2022
13:40 – 13:55
Friday, July 1, 2022
14:25 – 14:55
Friday, July 1, 2022
14:55 – 15:10
Friday, July 1, 2022
17:44 – 18:05